Urinary Mycobacterium szulgai infection in an immunocompetent patient
Abstract
Mycobacterium szulgai is one of the nontuberculous mycobacteria (NTM) and rarely causes diseases in human beings, particularly in immunocompetent patients. Less than 1% of all cases of NTM infection are caused by M szulgai, but the incidence is continuously increasing. Although extrapulmonary infections have been reported, most M szulgai infections are associated with pulmonary diseases. However, to our knowledge, a urinary tract infection caused by M szulgai has never before been reported. Here we report an immunocompetent female who experienced a urinary tract infection caused by M szulgai and was successfully treated with 4 months of isoniazid, rifampin, and levofloxacin.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.